Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT02953509 · TERMINATED
Trial details
- NCT number
- NCT02953509
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-21
- Primary completion
- 2024-03-25
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.